EMCURE.NS
Emcure Pharmaceuticals Ltd.
1W: +5.5%
1M: +10.8%
3M: +19.0%
YTD: +5.3%
1Y: +27.8%
₹1,633.20 ($17.35)
+39.80 (+2.50%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹302.1B ($3.2B)
52W Range889-1621.7
Volume524,419
Avg Volume236,779
Beta0.97
Dividend₹3.00
Analyst Ratings
No analyst coverage
Company Info
CEOSatish Ramanlal Mehta
Employees6,731
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2024-07-10
Websiteemcure.com
Plot No. P-1 and P-2
Pune 411057
IN
Pune 411057
IN
91 20 3507 0033
About Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found